PT Indofarma Tbk - Class B

ISX:INAF (Indonesia)   Class B
Rp 126.00 (0%) Dec 4
At Loss
Market Cap:
Rp 390.51B ($ 24.53M)
Enterprise V:
Rp 1.12T ($ 70.26M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Engineering Pharmaceutical, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing distribution, and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -1.28
Debt-to-Equity -0.81
Debt-to-EBITDA -1.4
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.87
Distress
Grey
Safe
Beneish M-Score -7.57
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -35.2
3-Year EPS without NRI Growth Rate -538.7
Name Current Vs Industry Vs History
9-Day RSI 11.23
14-Day RSI 21.51
6-1 Month Momentum % -37.62
12-1 Month Momentum % -74.7

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.15
Quick Ratio 0.1
Cash Ratio 0.01
Days Inventory 94.65
Days Sales Outstanding 145.11
Days Payable 461.86

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -7.44

Financials

ISX:INAF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

PT Indofarma Tbk Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil Rp) 215,767.568
EPS (TTM) (Rp) -224.506
Beta -0.33
Volatility % 100.03
14-Day RSI 21.51
14-Day ATR (Rp) 0.001362
20-Day SMA (Rp) 126
12-1 Month Momentum % -74.7
52-Week Range (Rp) 126 - 725
Shares Outstanding (Mil) 3,099.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PT Indofarma Tbk Filings

Filing Date Document Date Form
No Filing Data

PT Indofarma Tbk Stock Events

Financials Calendars
Event Date Price(Rp)
No Event Data

PT Indofarma Tbk Frequently Asked Questions

What is PT Indofarma Tbk(ISX:INAF)'s stock price today?
The current price of ISX:INAF is Rp126.00. The 52 week high of ISX:INAF is Rp725.00 and 52 week low is Rp126.00.
When is next earnings date of PT Indofarma Tbk(ISX:INAF)?
The next earnings date of PT Indofarma Tbk(ISX:INAF) is .
Does PT Indofarma Tbk(ISX:INAF) pay dividends? If so, how much?
PT Indofarma Tbk(ISX:INAF) does not pay dividend.

Press Release

Subject Date
No Press Release